Skip to content
← Full study record

NCT00287872 · MORE INFO

Limitations, agreements, and source contact

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma · Source last updated 2018-03-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
iborrell@jhmi.edu
organization
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
phone
(410) 955-4967
title
Dr. Ivan Borrello
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
iborrell@jhmi.edu
organization
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
phone
(410) 955-4967
title
Dr. Ivan Borrello

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice